Last updated: 1 March 2024 at 5:06pm EST

William Andrew Macan Net Worth




The estimated Net Worth of William Andrew Macan is at least $1.4 Million dollars as of 28 February 2024. William Macan owns over 28,403 units of Neuronetics Inc stock worth over $288,106 and over the last 6 years William sold STIM stock worth over $1,111,443.

William Macan STIM stock SEC Form 4 insiders trading

William has made over 20 trades of the Neuronetics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently William sold 28,403 units of STIM stock worth $88,333 on 28 February 2024.

The largest trade William's ever made was selling 34,991 units of Neuronetics Inc stock on 19 December 2023 worth over $87,128. On average, William trades about 7,625 units every 56 days since 2018. As of 28 February 2024 William still owns at least 389,333 units of Neuronetics Inc stock.

You can see the complete history of William Macan stock trades at the bottom of the page.



What's William Macan's mailing address?

William's mailing address filed with the SEC is C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.

Insiders trading at Neuronetics Inc

Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt und Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.



What does Neuronetics Inc do?

with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.



Complete history of William Macan stock trades at U.S. Silica Inc und Neuronetics Inc

Insider
Trans.
Transaktion
Gesamtpreis
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $88,333
28 Feb 2024
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $52,799
14 Feb 2024
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $18,255
5 Feb 2024
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $87,128
19 Dec 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $1,704
6 Oct 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $5,634
11 Jul 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $58,256
7 Mar 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $135,806
15 Feb 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $30,920
7 Feb 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $95,634
23 Jan 2023
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $4,739
7 Oct 2022
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $9,886
8 Jul 2022
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $33,134
7 Mar 2022
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $15,423
7 Feb 2022
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $40,698
24 Jan 2022
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $37,855
8 Jul 2021
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $125,067
9 Mar 2021
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Verkauf $270,171
22 Jan 2021
William Andrew Macan
EVP, Chefsyndikus, CCO und CS
Kauf $10,000
10 Mar 2020
William Andrew Macan
SVP General Counsel
Optionausübung $39,170
8 Nov 2019


Neuronetics Inc executives and stock owners

Neuronetics Inc executives and other stock owners filed with the SEC include: